Ibogaine

Bwiti: School of Life, Part 1

Bwiti: School of Life, Part 2

Bwiti: School of Life, Part 3

Bwiti: School of Life, Part 4

beōnd

Ibogaine: a review

The ibogaine medical subculture

Treatment of acute opioid withdrawal with ibogaine

Effects and aftereffects of ibogaine on morphine self-administration in rats

Inhibitory effects of ibogaine on cocaine self-administration in rats

Mechanisms of Antiaddictive Actions of Ibogainea

Ibogaine possesses a selective affinity for σ2 receptors

Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependencea

Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures

Ibogaine neurotoxicity: a re-evaluation

Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine

Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies

Radioligand-binding study of noribogaine, a likely metabolite of ibogaine

Ibogaine antagonizes cocaine-induced locomotor stimulation in mice

A preliminary investigation of ibogaine: case reports and recommendations for further study

Ibogaine in the treatment of heroin withdrawal

Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor

Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline

Ibogaine-like effects of noribogaine in rats

Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats

Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.

Ibogaine and its congeners are σ2 receptor-selective ligands with moderate affinity

NMDA antagonist properties of the putative antiaddictive drug, ibogaine.

Ibogaine induces glial activation in parasagittal zones of the cerebellum

Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin

Ibogaine reduces preference for cocaine consumption in C57BL/6By mice

Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration

Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study

Ibogaine in the treatment of substance dependence

Fatalities temporally associated with the ingestion of ibogaine

Pharmacodynamics and therapeutic applications of iboga and ibogaine

Serotonin transporter–ibogaine complexes illuminate mechanisms of inhibition and transport

Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption

Chemical Transformations of Ibogaine

The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity

The Alkaloids of Tabernanthe iboga. Part IV.1 The Structures of Ibogamine, Ibogaine, Tabernanthine and Voacangine

Use of ibogaine for treating neuropathic pain

Ibogaine therapy: A'Vast, uncontrolled experiment'

The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters

Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism

Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats

Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes

18‐Methoxycoronaridine (18‐MC) and Ibogaine: Comparison of antiaddictive efficacy, toxicity, and mechanisms of action

Ibogaine and the dopaminergic response to nicotine

Ibogaine: a potent noncompetitive blocker of ganglionic/neuronal nicotinic receptors

Attenuation of alcohol consumption by a novel nontoxic ibogaine analogue (18-methoxycoronaridine) in alcohol-preferring rats

The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine

The putative anti-addictive drug ibogaine is a competitive inhibitor of MK-801 binding to the NMDA receptor complex

Excitotoxic insult due to ibogaine leads to delayed induction of neuronal NOS in Purkinje cells.

Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter

How toxic is ibogaine?

Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review

Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine-dependent rat

Interaction of ibogaine and d-amphetamine: in vivo microdialysis and motor behavior in rats

Potentiation action of ibogaine (bogadin TM) on morphine analgesia

Treating drug dependence with the aid of ibogaine: A retrospective study

The structure of ibogaine

Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors

Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine

Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine

Effects of ibogaine on naloxone‐precipitated withdrawal in morphine‐dependent mice

Ibogaine block of the NMDA receptor: in vitro and in vivo studies

Long-QT syndrome induced by the antiaddiction drug ibogaine

Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior.

Neurochemical and behavioural interactions between ibogaine and nicotine in the rat

In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats

Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research

Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex

Iboga Alkaloids. II.1 the Structures of Ibogaine, Ibogamine and Tabernanthine

Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca

Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity

Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats

The use of ibogaine in the treatment of addictions

High affinity ibogaine binding to a mu opioid agonist site

Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation

Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener

Ibogaine-associated ventricular tachyarrhythmias

Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine

The anti-addiction drug ibogaine and the heart: a delicate relation

Life-threatening complications of ibogaine: three case reports

Ibogaine modulates cocaine responses which are altered due to environmental habituation: in vivo microvoltammetric and behavioral studies

Acute toxicity of ibogaine and noribogaine

Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study

Ibogaine selectively inhibits nicotinic receptor-mediated catecholamine release

Ibogaine affects brain energy metabolism

Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors

Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats

Facilitation of memory retrieval by the “anti-addictive” alkaloid, ibogaine

Cardiac arrest after ibogaine ingestion

Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors

Bioactive tricyclic ibogaine analogs

DARK classics in chemical neuroscience: Ibogaine

Anti‐addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk

Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction

A contemporary history of ibogaine in the United States and Europe

Autoregulation of glial cell line‐derived neurotrophic factor expression: implications for the long‐lasting actions of the anti‐addiction drug, Ibogaine

Differential effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamine

A dose-response study of ibogaine-induced neuropathology in the rat cerebellum

Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum

Ibogaine, a putatively anti-addictive alkaloid

Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD

Case studies of ibogaine treatment: implications for patient management strategies

Evidence for roles of κ-opioid and NMDA receptors in the mechanism of action of ibogaine

Identification and Quantitation of Ibogaine and an o-Demethylated Metabolite in Brain and Biological Fluids Using Gas Chromatography-Mass Spectrometry

Ibogaine related sudden death: a case report

Long-lasting ibogaine protection against NMDA-induced convulsions in mice

Distribution of Ibogaine and Noribogaine in a Man Following a Poisoning Involving Root Bark of the Tabernanthe iboga Shrub

Modulation of morphine-induced antinociception by ibogaine and noribogaine

Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions with d-amphetamine

Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry

Total synthesis of ibogaine, epiibogaine and their analogues

Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation

Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats

Noribogaine (12‐hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaine

Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus

Effects of ibogaine, and cocaine and morphine after ibogaine, on ventral tegmental dopamine neurons

Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brain

Noribogaine, but not 18‐MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self‐administration

Ibogaine and the inhibition of acetylcholinesterase

Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release

The need for ibogaine in drug and alcohol addiction treatment

Effects of chronic ibogaine treatment on cerebellar Purkinje cells in the rat

Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction

Determination of ibogaine in plasma by gas chromatography-chemical ionization mass spectrometry

Neuropharmacological characterization of local ibogaine effects on dopamine release

Effect of ibogaine on cocaine-induced efflux of dopamine and serotonin from mouse striatum

Effects of ibogaine on sensory-motor function, activity, and spatial learning in rats

Ibogaine and addiction in the animal model, a systematic review and meta-analysis

Ibogaine and noribogaine: comparing parent compound to metabolite

Growing menace of ibogaine toxicity

Modified Ibogaine Fragments: Synthesis and Preliminary Pharmacological Characterization of 3-Ethyl-5-phenyl-1,2,3,4,5,6-hexahydroazepino …

Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile

Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine

Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections

Ibogaine as a glutamate antagonist: relevance to its putative antiaddictive properties

Ibogaine analogues. Synthesis and preliminary pharmacological evaluation of 7-heteroaryl-2-azabicyclo oct-7-enes

Changes in withdrawal and craving scores in participants undergoing opioid detoxification utilizing ibogaine

The identification of ibogaine in biological material

Ibogaine alters synaptosomal and glial glutamate release and uptake

Ibogaine: Proceedings from the First International Conference

Abbreviated ibogaine congeners. Synthesis and reactions of tropan-3-yl-2-and-3-indoles. Investigation of an unusual isomerization of 2-substituted indoles using …

Responses of the extrapyramidal and limbic substance P systems to ibogaine and cocaine treatments

Use of ibogaine in reducing excitotoxic brain damage

Ibogaine attenuates morphine-induced conditioned place preference.

Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats

Interaction of ibogaine with human α3β4-nicotinic acetylcholine receptors in different conformational states

Ibogaine signals addiction genes and methamphetamine alteration of long‐term potentiation

Drug discrimination studies with ibogaine

Anxiogenic action of ibogaine

Ibogaine and Subjective Experience: Transformative States and Psychopharmacotherapy in the Treatment of Opioid Use Disorder

Ibogaine and noribogaine potentiate the inhibition of adenylyl cyclase activity by opioid and 5-HT receptors

The effect of ibogaine on κ-opioid-and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6BY mice

Ibogaine for treating drug dependence. What is a safe dose?

Effect of Ibogaine on the Various Sites of the NMDA Receptor Complex and Sigma Binding Sites in Rat Braina

The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes

Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine

Determination of ibogaine and 12-hydroxy-ibogamine in plasma by gas chromatography-positive ion chemical ionization-mass spectrometry

Effects of LSD 25, BOL 148, bufotenine, mescaline and ibogaine on the potentiation of hexobarbital hypnosis produced by serotonin and reserpine

Cytochrome P450 and O-methyltransferase catalyze the final steps in the biosynthesis of the anti-addictive alkaloid ibogaine from Tabernanthe iboga

Ibogaine detoxification transitions opioid and cocaine abusers between dependence and abstinence: clinical observations and treatment outcomes

Characterization of the discriminable stimulus produced by 2‐BFI: effects of imidazoline I2‐site ligands, MAOIs, β‐carbolines, agmatine and ibogaine

Characterization of multiple sites of action of ibogaine

Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine

Effects of ibogaine on the development of tolerance to antinociceptive action of μ-, δ-and κ-opioid receptor agonists in mice

Ibogaine enhances the expression of locomotor sensitization in rats chronically treated with cocaine

Alteration in electroencephalogram and monoamine concentrations in rat brain following ibogaine treatment

Ibogaine therapy for substance abuse disorders

Comparative neurobiological effects of ibogaine and MK-801 in rats

Effects of ibogaine and noribogaine on the antinociceptive action of μ-, δ-and κ-opioid receptor agonists in mice

The effect of ibogaine on sigma-and NMDA-receptor-mediated release of dopamine

Ibogaine acute administration in rats promotes wakefulness, long-lasting REM sleep suppression, and a distinctive motor profile

The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus

Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine

Tabernanthine, ibogaine containing analgesic compositions

Determination of ibogaine and noribogaine in biological fluids and hair by LC–MS/MS after Tabernanthe iboga abuse: Iboga alkaloids distribution in a drowning death …

A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma …

Derivatives of ibogamine, ibogaine and ibogaline lactams

Disposition of ibogaine in the rat

Enhancement of morphine antinociception by ibogaine and noribogaine in morphine-tolerant mice

Pharmacokinetic characterization of the indole alkaloid ibogaine in rats

Effects of ibogaine and noribogaine on phosphoinositide hydrolysis

Treating drug dependence with the aid of ibogaine: A qualitative study

Ibogaine interferes with the establishment of amphetamine place preference learning.

Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers

Failure of ibogaine to produce phencyclidine-like discriminative stimulus effects in rats and monkeys

In Vivo Ibogaine Blockade and In Vitro PKC Action of Cocainea

Effects of ibogaine on performance in the 8-arm radial maze

From the roots up: ibogaine and addict self-help

Ibogaine blocked methamphetamine-induced hyperthermia and induction of heat shock protein in mice

Ibogaine fails to interrupt the expression of a previously established one-trial morphine place preference.

Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats

Effects of low dose ibogaine on subjective mood state and psychological performance

Mania following use of ibogaine: A case series

Liquid chromatography–electrospray mass spectrometry determination of ibogaine and noribogaine in human plasma and whole blood: Application to a poisoning …

Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review

Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19

Acute ibogaine injection induces expression of the immediate early genes, egr-1 and c-fos, in mouse brain

Internet-purchased ibogaine toxicity confirmed with serum, urine, and product content levels

Remission of severe opioid Use disorder with ibogaine: a case report

Ibogaine neurotoxicity assessment: electrophysiological, neurochemical, and neurohistological methods

Modulation of the effects of rewarding drugs by ibogaine

Manual for ibogaine therapy: screening, safety, monitoring & aftercare

Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands

The antiaddictive effects of ibogaine: A systematic literature review of human studies

Acute and chronic administration of ibogaine to the rat results in astrogliosis that is not confined to the cerebellar vermis

The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus

Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: Effects on tremors induced by oxotremorine, harmine and ibogaine a comparison with …

Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short-and long-term outcomes and current psychological functioning

A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment

Metabolic plasticity and the energy economizing effect of ibogaine, the principal alkaloid of Tabernanthe iboga

Neurochemical and neuroendocrine effects of ibogaine in rats: Comparison to MK‐801

Ibogaine-associated cardiac arrest and death: case report and review of the literature

Fatal Case of a 27‐Year‐Old Male After Taking Iboga in Withdrawal Treatment: GC‐MS/MS Determination of Ibogaine and Ibogamine in Iboga Roots and Postmortem …

Ibogaine and a total alkaloidal extract of Voacanga africana modulate neuronal excitability and synaptic transmission in the rat parabrachial nucleus in vitro

Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of internet purchased ibogaine

Ibogaine therapy for addiction: Consumer views from online fora

The mystery of ibogaine: can an African psychedelic cure addiction?

Ibogaine-associated psychosis in schizophrenia: a case report

Administration of a non-NMDA antagonist, GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine

A mixed-method analysis of persisting effects associated with positive outcomes following ibogaine detoxification

Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity

Ibogaine: A novel anti-addictive compound

Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine …

Quantification of Anti‐Addictive Alkaloids Ibogaine and Voacangine in In Vivo‐ and In Vitro‐Grown Plants of Two Mexican Tabernaemontana Species

Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine

Structure of ibogaine

Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus.

Metallation/reduction as a new approach to tritium labeling. The synthesis of ibogaine

Ibogaine in the treatment of narcotic withdrawal

The development and expression of locomotor sensitization to nicotine in the presence of ibogaine

100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.

Ibogaine in the 21st century: boosters, tuneups and maintenance

The anti-addictive drug ibogaine modulates voltage-gated ion channels and may trigger cardiac arrhythmias

Quantitation of ibogaine and 12-hydroxyibogamine in human plasma by liquid chromatography with fluorimetric detection

A preliminary report on the safety and pharmacokinetics of ibogaine

Sur l'ibogaine

A Single Administration of the Atypical Psychedelic Ibogaine or its Metabolite Noribogaine Induces an Antidepressant-like Effect in Rats

Examination of the phenomenology of the ibogaine treatment experience: Role of altered states of consciousness and psychedelic experiences

Ibogaine administration modifies GDNF and BDNF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits

Ibogaine as a treatment for substance misuse: potential benefits and practical dangers

Understanding the healing potential of ibogaine through a comparative and interpretive phenomenology of the visionary experience

Methods and compositions for reducing tolerance to opioid analgesics using ibogaine and derivatives thereof

Detection and Identification of Ibogaine and Heroin

The effects of β-carbolines in rats trained with ibogaine as a discriminative stimulus

Ibogaine-structure, influence on human body, clinical relevance

Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood–brain barrier

Detoxification from methadone using low, repeated, and increasing doses of ibogaine: A case report

Breaking the cycle of opioid use disorder with ibogaine

Methods for acute and long-term treatment of substance abuse using ibogaine

Induction of energy metabolism related enzymes in yeast Saccharomyces cerevisiae exposed to ibogaine is adaptation to acute decrease in ATP energy pool

A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder

Solution-phase parallel synthesis of N, 6-disubstituted isoquinuclidines as ibogaine analogs

“Herbal seizures”–atypical symptoms after ibogaine intoxication: a case report

Structure–activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states

Liquid chromatography-electrospray mass spectrometry determination of ibogaine and 12-hydroxy-ibogamine in human urine

A phenomenological investigation into the lived experience of ibogaine and its potential to treat opioid use disorders

Extraction and Conversion Studies of the Antiaddictive Alkaloids Coronaridine, Ibogamine, Voacangine, and Ibogaine from Two Mexican Tabernaemontana Species …

Ex vivo effects of ibogaine on the activity of antioxidative enzymes in human erythrocytes

Investigation into pharmacokinetic properties of active alkaloid ibogaine and its metabolite noribogaine

Ibogaine therapy in the treatment of opiate dependency

Ibogaine interferes with the establishment of conditioned taste avoidance produced by morphine and lithium

Neuropharmacological studies on ibogaine, an indole alkaloid with central-stimulant properties.

Anti-addiction drug ibogaine prolongs the action potential in human induced pluripotent stem cell-derived cardiomyocytes

Cardiac arrest after ibogaine intoxication

The effects of ibogaine on uterine smooth muscle contractions: relation to the activity of antioxidant enzymes

Ibogaine and Noribogaine: Structural Analysis and Stability Studies. Use of LC‐MS to Determine Alkaloid Contents of the Root Bark of Tabernanthe Iboga

Ibogaine produces neurodegeneration in rat, but not mouse, cerebellum: Neurohistological biomarkers of Purkinje cell loss

Assessment of neurotoxicity from potential medications for drug abuse: ibogaine testing and brain imaging

Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action

The Ibogaine Experience: A Qualitative Study on the Acute Subjective Effects of Ibogaine

Ibogaine and the treatment of opiate addiction

Combating substance abuse with ibogaine: Pre-and posttreatment recommendations and an example of successive model fitting analyses

A new approach to tritium labelling; the synthesis of ibogaine

Application of electrophysiological method to study interactions between ibogaine and cocaine

Ibogaine II: down memory lane; does one trip equal 30 years on a therapist's couch?

Effect of ibogaine on the development of tolerance to the analgesic effect of morphine.

Pharmacological comparison of the effect of ibogaine and 18‐methoxycoronaridine on isolated smooth muscle from the rat and guinea‐pig

Life after ibogaine

Ibogaine: therapeutic miracle

A COMPARATIVE STUDY ON THE TOXICITY OF IBOGAINE AND SEROTONIN.

Ibogaine Treatment in Aotearoa/New Zealand: Developing a unique model of practice

Cardiac arrest after ibogaine ingestion

Hallucinogen persisting perception disorder after ibogaine treatment for opioid dependence

Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias

Methods and compositions for treating depression using ibogaine

An analytical study of iboga alkaloids contained in Tabernanthe iboga-derived products offered by ibogaine treatment providers

Ibogaine in acute opioid withdrawal: An open label case series

Low dose administration of ibogaine for treating nicotine addiction and preventing relapse of nicotine use

Ibogaine offers an alternative approach for treating opiate addiction

NOS and fos in Rat and Mouse Brain Regions: Possible Relation to Ibogaine‐Induced Purkinje Cell Loss

Analysis of the cardiovascular action of ibogaine hydrochloride.

Anesthesia for opiate detoxification and the ibogaine controversy

Development of novel medications for drug addiction: The legacy of an African shrub

Observations on treatment with ibogaine.

Changes in gene expression and signal transduction following ibogaine treatment

The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug's proarrhythmic potential

Novel treatment of opioid use disorder using ibogaine and iboga in two adults

… effect of alkaloids from Tabernanthe iboga H. Bn. on the response of isolated organs to catecholamines and the possible role of calcium exchange. Case of Ibogaine

Methods for acute and long-term treatment of alcohol dependence using ibogaine

The visionary cure of the addiction war? Ibogaine: social context, subcultural identity, and implications for drug policy

Biosynthesis of the Iboga alkaloids: the incorporation of tryptophan-3-C14 into ibogaine

lbogaine Alters Cocaine-Induced Biogenic Amine and Psychostimulant Dysfunction but not GBR-12935 Binding to the Dopamine Transporter Protein

N-(Hydroxymethyl) ibogaine

Gamma band alterations and REM-like traits underpin the acute effect of the atypical psychedelic ibogaine

Interactions between ibogaine and morphine: Neuropharmacological and pharmacokinetic determinants.

Detection de l'ibogaine dans les liquides organiques

… of Ibogaine and Ibogaine-Related Alkaloids. in The Alkaloids. Chemistry and Biology Pharmacology of Ibogaine and Ibogaine-Related Alkaloids. in The …

N-(Hydroxymethyl) ibogaine

Gamma band alterations and REM-like traits underpin the acute effect of the atypical psychedelic ibogaine

Interactions between ibogaine and morphine: Neuropharmacological and pharmacokinetic determinants.

Detection de l'ibogaine dans les liquides organiques

… of Ibogaine and Ibogaine-Related Alkaloids. in The Alkaloids. Chemistry and Biology Pharmacology of Ibogaine and Ibogaine-Related Alkaloids. in The …

N-(Hydroxymethyl) ibogaine

Gamma band alterations and REM-like traits underpin the acute effect of the atypical psychedelic ibogaine

Interactions between ibogaine and morphine: Neuropharmacological and pharmacokinetic determinants.

Detection de l'ibogaine dans les liquides organiques

N-(Hydroxymethyl) ibogaine

Gamma band alterations and REM-like traits underpin the acute effect of the atypical psychedelic ibogaine

Interactions between ibogaine and morphine: Neuropharmacological and pharmacokinetic determinants.

Gamma band alterations and REM-like traits underpin the acute effect of the atypical psychedelic ibogaine

Interactions between ibogaine and morphine: Neuropharmacological and pharmacokinetic determinants.

Gamma band alterations and REM-like traits underpin the acute effect of the atypical psychedelic ibogaine

Interactions between ibogaine and morphine: Neuropharmacological and pharmacokinetic determinants.

Methods for the detection and determination of ibogaine in biological materials.

A case of QT prolongation and torsades de pointes caused by ibogaine toxicity

Anti-addiction drug ibogaine on trial

Ibogaine Toxicity In A Case Of Good Intentions

IBOGAINE MAY HELP DRUG ADDICTS LIVE THE 'NEVER AGAIN'

Ibogaine Binds Human Serotonin Transporter in Multiple Functional States

QTC prolongation progressing to torsade de pointes secondary to ibogaine ingestion

Experiences of opioid detoxification using ibogaine in various treatment settings: Exploring ibogaine users' motivations, understanding of risks, and effects of ibogaine …

An approach to the synthesis of ibogaine

Psychedelics and quasi-psychedelics in the light of contemporary research: Medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca

Effects of ibogaine per os application on redox homeostasis in rat liver and erythrocytes

A tropane-based ibogaine analog rescues folding-deficient SERT and DAT

Potential use of medicinal plants in the treatment of alcoholism

Ibogaine modifies GDNF, BDNF and NGF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits

Thin Layer Chromatography of Lysergic Acid Diethylamide (LSD), N, N Dimethyl Tryptamine (DMT), Methylene Dioxyphenyl Isopropylamine (STP), and Ibogaine

Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake

Serotonin transporter–ibogaine complexes illuminate mechanisms of inhibition and transport

Gas chromatographic determination of iboga ine in biological fluids

Ibogaine

Ibogaine overdose

Ibogaine overdose

Clinical and Demographic Profile Analysis of Patients Receiving Ibogaine Treatment for Substance Use Disorders in Mexico

Ibogaine overdose

Ibogaine abuse

Ibogaine: History, Pharmacology, Spirituality, & Clinical Data

Ibogaine “

The Phenomenology of Ibogaine-assisted Addiction Therapy: Understanding the Role of the Visionary Experience in Healing

Pharmacology of ibogaine and ibogaine-related alkaloids

Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification

Ibogaine in the Treatment of Alcoholism: a Randomized, Double-blind, Placebo-controlled, Escalating-dose, Phase 2 Trial

Personality and Drug Use (PDU)

Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use